These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24461493)

  • 1. Synthesis and biological evaluation of coumarin replacements of novobiocin as Hsp90 inhibitors.
    Kusuma BR; Khandelwal A; Gu W; Brown D; Liu W; Vielhauer G; Holzbeierlein J; Blagg BS
    Bioorg Med Chem; 2014 Feb; 22(4):1441-9. PubMed ID: 24461493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The design, synthesis, and evaluation of coumarin ring derivatives of the novobiocin scaffold that exhibit antiproliferative activity.
    Donnelly AC; Mays JR; Burlison JA; Nelson JT; Vielhauer G; Holzbeierlein J; Blagg BS
    J Org Chem; 2008 Nov; 73(22):8901-20. PubMed ID: 18939877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and Biological Evaluation of Novobiocin Core Analogues as Hsp90 Inhibitors.
    Byrd KM; Subramanian C; Sanchez J; Motiwala HF; Liu W; Cohen MS; Holzbeierlein J; Blagg BS
    Chemistry; 2016 May; 22(20):6921-31. PubMed ID: 27037933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering an antibiotic to fight cancer: optimization of the novobiocin scaffold to produce anti-proliferative agents.
    Zhao H; Donnelly AC; Kusuma BR; Brandt GE; Brown D; Rajewski RA; Vielhauer G; Holzbeierlein J; Cohen MS; Blagg BS
    J Med Chem; 2011 Jun; 54(11):3839-53. PubMed ID: 21553822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antiproliferative activity of novobiocin analogues as potential hsp90 inhibitors.
    Audisio D; Methy-Gonnot D; Radanyi C; Renoir JM; Denis S; Sauvage F; Vergnaud-Gauduchon J; Brion JD; Messaoudi S; Alami M
    Eur J Med Chem; 2014 Aug; 83():498-507. PubMed ID: 24992077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novobiocin and additional inhibitors of the Hsp90 C-terminal nucleotide-binding pocket.
    Donnelly A; Blagg BS
    Curr Med Chem; 2008; 15(26):2702-17. PubMed ID: 18991631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Click chemistry to probe Hsp90: Synthesis and evaluation of a series of triazole-containing novobiocin analogues.
    Peterson LB; Blagg BS
    Bioorg Med Chem Lett; 2010 Jul; 20(13):3957-60. PubMed ID: 20570149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The synthesis and evaluation of flavone and isoflavone chimeras of novobiocin and derrubone.
    Mays JR; Hill SA; Moyers JT; Blagg BS
    Bioorg Med Chem; 2010 Jan; 18(1):249-66. PubMed ID: 19932969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of novobiocin analogues that manifest anti-proliferative activity against several cancer cell lines.
    Burlison JA; Avila C; Vielhauer G; Lubbers DJ; Holzbeierlein J; Blagg BS
    J Org Chem; 2008 Mar; 73(6):2130-7. PubMed ID: 18293999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of arylated novobiocin analogs as Hsp90 inhibitors.
    Kusuma BR; Duerfeldt AS; Blagg BS
    Bioorg Med Chem Lett; 2011 Dec; 21(23):7170-4. PubMed ID: 22014546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of novobiocin analogues as potential heat shock protein 90 inhibitors.
    Gunaherath GM; Marron MT; Wijeratne EM; Whitesell L; Gunatilaka AA
    Bioorg Med Chem; 2013 Sep; 21(17):5118-29. PubMed ID: 23859777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novobiocin Analogs as Potential Anticancer Agents.
    Dlugosz A; Janecka A
    Mini Rev Med Chem; 2017; 17(9):728-733. PubMed ID: 28019639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novobiocin Analogues That Inhibit the MAPK Pathway.
    Hall JA; Seedarala S; Zhao H; Garg G; Ghosh S; Blagg BS
    J Med Chem; 2016 Feb; 59(3):925-33. PubMed ID: 26745854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Phenyl Cyclohexylcarboxamides as a Novel Class of Hsp90 C-terminal Inhibitors.
    Garg G; Forsberg LK; Zhao H; Blagg BSJ
    Chemistry; 2017 Nov; 23(65):16574-16585. PubMed ID: 28940589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological activity of simplified denoviose-coumarins related to novobiocin as potent inhibitors of heat-shock protein 90 (hsp90).
    Radanyi C; Le Bras G; Messaoudi S; Bouclier C; Peyrat JF; Brion JD; Marsaud V; Renoir JM; Alami M
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2495-8. PubMed ID: 18304811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and biological evaluation of alkylamino biphenylamides as Hsp90 C-terminal inhibitors.
    Garg G; Zhao H; Blagg BS
    Bioorg Med Chem; 2017 Jan; 25(2):451-457. PubMed ID: 27914946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novobiocin and related coumarins and depletion of heat shock protein 90-dependent signaling proteins.
    Marcu MG; Schulte TW; Neckers L
    J Natl Cancer Inst; 2000 Feb; 92(3):242-8. PubMed ID: 10655441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A library of noviosylated coumarin analogues.
    Huang YT; Blagg BS
    J Org Chem; 2007 May; 72(10):3609-13. PubMed ID: 17328573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploiting polarity and chirality to probe the Hsp90 C-terminus.
    Forsberg LK; Davis RE; Wimalasena VK; Blagg BSJ
    Bioorg Med Chem; 2018 Jul; 26(12):3096-3110. PubMed ID: 29720349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novobiocin-ferrocene conjugates possessing anticancer and antiplasmodial activity independent of HSP90 inhibition.
    Mbaba M; de la Mare JA; Sterrenberg JN; Kajewole D; Maharaj S; Edkins AL; Isaacs M; Hoppe HC; Khanye SD
    J Biol Inorg Chem; 2019 Mar; 24(2):139-149. PubMed ID: 30542925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.